NTLA
Intellia Therapeutics Inc
12.30$
-2.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +172.7% | +58.5% | +16.5% | +41.6% | +34.5% | -43.0% | +57.7% | -30.4% | +59.6% | +16.9% | |
| – | +573.9% | +185.0% | +112.5% | +31.7% | +21.7% | +38.7% | -95.4% | +9.9% | +18.5% | +14.6% | +54.8% | |
| – | – | – | +58.5% | +16.5% | -314.6% | – | -43.0% | +34.8% | -38.7% | +74.3% | +8.7% | |
| – | +4.0% | +185.0% | +112.5% | +31.7% | +21.7% | +38.7% | +52.8% | +82.8% | +3.6% | +7.2% | -16.6% | |
| – | +132.1% | +102.8% | +66.8% | +14.9% | +27.6% | +7.6% | +61.0% | +27.0% | +29.0% | +8.0% | -4.8% | |
| – | +53.8% | +150.0% | +96.7% | +26.8% | -66.2% | +373.9% | +54.6% | +67.1% | +7.9% | +7.2% | -15.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +193.0% | +24.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -223.7% | – | – | – | -410.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.